As much of the nation deals with the effects of opioid addiction and overuse, some states are attempting to hold the makers of these drugs accountable. Once again, Purdue Pharma, the company behind OxyContin and other opioid painkillers, finds itself in the crosshairs of allegations that it has continued to contribute to this epidemic by deceiving patients and physicians about the safety and efficacy of these drugs. [More]
purdue pharma
New Hampshire Accuses OxyContin Maker Of Stoking Opioid Epidemic Through Deceptive Marketing
By 8.9.17
Ohio: Makers Of OxyContin, Percocet & Other Opioids Helped Fuel Drug Epidemic By Misleading Doctors, Patients
By 5.31.17
As Americans nationwide deal with the ongoing opioid epidemic, which has also resulted in the resurrection of heroin in many parts of the country, the Ohio Attorney General is accusing five major pharmaceutical companies of misleading the public about the safety and benefits of opioid painkillers. [More]
Report: OxyContin Makers Ignored Internal Warnings Of “Organized Drug Ring” & Pill Mills
By 7.18.16
As the current opioid addiction/overdose epidemic spread out across America over the last 20 years, it wasn’t just greedy drugstore chains that turned a blind eye to fake and questionable prescriptions. A new report highlights how the company behind one of the epidemic’s signature drugs ignored warning signs of obvious illegal activity. [More]
Report: Makers Of OxyContin Knew For Decades That Pain Pills Could Wear Off Early
By 5.5.16
When OxyContin hit pharmacies 20 years ago, its primary selling point was that a single dose of the opioid pain medication lasted 12 hours, “providing smooth and sustained pain control all day and all night,” per the press release. But a new report claims Purdue Pharma, the makers of OxyContin, have long known that the drug doesn’t always live up to this promise, resulting in an increased likelihood for abuse and addiction. [More]
Maker Of OxyContin Believes Children Are The Future (For Extending Its Patent)
By 7.3.12
The company that makes OxyContin has a good thing going, with lots of free PR from shows like Intervention and Justified and no exact generic equivalent to undercut its market share. But there are dark clouds on the horizon for the OxyContin brand, as its patent is set to expire in April. Now, in a ploy to extend that patent, the Oxy folks are going through the motions of pretending they actually care whether or not children can take the drug safely. [More]
